Metoject®

Metoject is indicated for the treatment of:

• Active rheumatoid arthritis in adult patients.
• Severe active polyarticular juvenile idiopathic arthritis when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
• Severe refractory and disabling psoriasis that does not adequately respond to other treatments such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patients.
• Mild to moderate Crohn’s disease in adult patients when adequate treatment with other medications is not possible.

• Metoject 7,5 mg/0,15 ml, 1 pre-filled syringe
• Metoject 7,5 mg/0,15 ml, 4 pre-filled syringes
• Metoject 10 mg/0,20 ml, 1 pre-filled syringe
• Metoject 10 mg/0,20 ml, 4 pre-filled syringes
• Metoject 12,5 mg/0,25 ml, 1 pre-filled syringe
• Metoject 12,5 mg/0,25 ml, 4 pre-filled syringes
• Metoject 15 mg/0,30 ml, 1 pre-filled syringe
• Metoject 15 mg/0,30 ml, 4 pre-filled syringes
• Metoject 17,5 mg/0,35 ml, 1 pre-filled syringe
• Metoject 17,5 mg/0,35 ml, 4 pre-filled syringes
• Metoject 20 mg/0,40 ml, 1 pre-filled syringe
• Metoject 20 mg/0,40 ml, 4 pre-filled syringes
• Metoject 22,5 mg/0,45 ml, 1 pre-filled syringe
• Metoject 22,5 mg/0,45 ml, 4 pre-filled syringes
• Metoject 25 mg/0,50 ml, 1 pre-filled syringe
• Metoject 25 mg/0,50 ml, 4 pre-filled syringes
• Metoject 27,5 mg/0,55 ml, 1 pre-filled syringe
• Metoject 27,5 mg/0,55 ml, 4 pre-filled syringes
• Metoject 30 mg/0,60 ml, 1 pre-filled syringe
• Metoject 30 mg/0,60 ml, 4 pre-filled syringes